Copyright © 2012 Jacqueline M. Evans et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Allograft survival can be prolonged by overexpression of cytoprotective genes such as heme oxygenase-1 (HO-1). Modifications in vector design and delivery have provided new opportunities to safely and effectively administer HO-1 into the heart prior to transplantation to improve long-term graft outcome. Methods. HO-1 was delivered to the donor heart using an adeno-associated virus vector (AAV) with a pseudotype 6 capsid and vascular endothelial growth factor (VEGF) to enha...
Cardiac gene transfer is an attractive tool for developing novel heart disease treatments. Adeno-ass...
BACKGROUND: Allograft tolerance might be achieved by expressing immunomodulatory proteins through ge...
Gene therapy is an advanced treatment approach that alters the genetic composition of cells to confe...
Background - Allograft deterioration is the major obstacle to organ transplantation as a long-term t...
Background—Allograft deterioration is the major obstacle to organ transplantation as a long-term tre...
The online version of this article, along with updated information and services, is located on th
Heart transplantation is currently a viable option for the treatment of patients with end-stage card...
Objectives: Conditions for ex vivo gene transfer to the transplanted heart were studied in a model o...
Current treatments of heart transplantation are limited by incomplete effectiveness, significant tox...
The rejection of concordant xenografts, such as mouse-to-rat cardiac xenografts, is very similar to ...
ObjectivesThe goal of this study was to modify mesenchymal stem cells (MSCs) cells with a hypoxia-re...
Objectives: Conditions for ex vivo gene transfer to the transplanted heart were studied in a model o...
Background: In this investigation we studied the efficacy and durability of recombinant adeno-associ...
Efficient durable viral vector transduction of the transplanted heart remains elusive. This study as...
Cardiac gene transfer is a potentially useful treatment for patients with heart disease. The adeno-a...
Cardiac gene transfer is an attractive tool for developing novel heart disease treatments. Adeno-ass...
BACKGROUND: Allograft tolerance might be achieved by expressing immunomodulatory proteins through ge...
Gene therapy is an advanced treatment approach that alters the genetic composition of cells to confe...
Background - Allograft deterioration is the major obstacle to organ transplantation as a long-term t...
Background—Allograft deterioration is the major obstacle to organ transplantation as a long-term tre...
The online version of this article, along with updated information and services, is located on th
Heart transplantation is currently a viable option for the treatment of patients with end-stage card...
Objectives: Conditions for ex vivo gene transfer to the transplanted heart were studied in a model o...
Current treatments of heart transplantation are limited by incomplete effectiveness, significant tox...
The rejection of concordant xenografts, such as mouse-to-rat cardiac xenografts, is very similar to ...
ObjectivesThe goal of this study was to modify mesenchymal stem cells (MSCs) cells with a hypoxia-re...
Objectives: Conditions for ex vivo gene transfer to the transplanted heart were studied in a model o...
Background: In this investigation we studied the efficacy and durability of recombinant adeno-associ...
Efficient durable viral vector transduction of the transplanted heart remains elusive. This study as...
Cardiac gene transfer is a potentially useful treatment for patients with heart disease. The adeno-a...
Cardiac gene transfer is an attractive tool for developing novel heart disease treatments. Adeno-ass...
BACKGROUND: Allograft tolerance might be achieved by expressing immunomodulatory proteins through ge...
Gene therapy is an advanced treatment approach that alters the genetic composition of cells to confe...